David Kim1, Denise Mackenzie2, Rick Cutfield1. 1. Department of General Medicine, Waitemata District Health Board, New Zealand. 2. Department of Endocrinology, Waitemata District Health Board, New Zealand.
Abstract
AIM: To analyse the performance of a Fracture Liaison Service (FLS) at Waitemata District Health Board (WDHB), and to detail how systematic secondary fracture prevention can be delivered in a secondary healthcare setting in New Zealand. METHOD: Clinical details of patients supervised by the WDHB FLS during the calendar year 2014 were reviewed and analysed. Additional information including treatment compliance and re-fracture rates were sought a year after initial intervention. RESULTS: During the 12-month period, 301 patients with fragility fracture were seen by the WDHB FLS. All patients had clinical and laboratory assessment, one-to-one education by the FLS co-ordinator. One hundred and twenty-one patients had dual energy x-ray absorptiometry (DEXA) performed. One hundred and thirty-four of 226 treatment naive patients were started or recommended to be started on a bone protection therapy, bisphosphonate in almost all cases, and another 25 of 75 patients had adjustment made to their current therapy. Of those who were started or continued on treatment, adherence rate was 70% at a mean follow-up of 12 months. CONCLUSION: An effective secondary fracture prevention programme, such as a FLS, can be successfully implemented in a New Zealand district hospital setting.
AIM: To analyse the performance of a Fracture Liaison Service (FLS) at Waitemata District Health Board (WDHB), and to detail how systematic secondary fracture prevention can be delivered in a secondary healthcare setting in New Zealand. METHOD: Clinical details of patients supervised by the WDHB FLS during the calendar year 2014 were reviewed and analysed. Additional information including treatment compliance and re-fracture rates were sought a year after initial intervention. RESULTS: During the 12-month period, 301 patients with fragility fracture were seen by the WDHB FLS. All patients had clinical and laboratory assessment, one-to-one education by the FLS co-ordinator. One hundred and twenty-one patients had dual energy x-ray absorptiometry (DEXA) performed. One hundred and thirty-four of 226 treatment naive patients were started or recommended to be started on a bone protection therapy, bisphosphonate in almost all cases, and another 25 of 75 patients had adjustment made to their current therapy. Of those who were started or continued on treatment, adherence rate was 70% at a mean follow-up of 12 months. CONCLUSION: An effective secondary fracture prevention programme, such as a FLS, can be successfully implemented in a New Zealand district hospital setting.
Authors: P R Ebeling; D-C Chan; T C Lau; J K Lee; T Songpatanasilp; S H Wong; F L Hew; R Sethi; M Williams Journal: Osteoporos Int Date: 2019-12-01 Impact factor: 4.507
Authors: Christine Ellen Gill; Paul James Mitchell; Jan Clark; Jillian Cornish; Peter Fergusson; Nigel Gilchrist; Lynne Hayman; Sue Hornblow; David Kim; Denise Mackenzie; Stella Milsom; Adrienne von Tunzelmann; Elizabeth Binns; Kim Fergusson; Stewart Fleming; Sarah Hurring; Rebbecca Lilley; Caroline Miller; Pierre Navarre; Andrea Pettett; Shankar Sankaran; Min Yee Seow; Jenny Sincock; Nicola Ward; Mark Wright; Jacqueline Clare Therese Close; Ian Andrew Harris; Elizabeth Armstrong; Jamie Hallen; Joanna Hikaka; Ngaire Kerse; Andrea Vujnovich; Kirtan Ganda; Markus Joachim Seibel; Thomas Jackson; Paul Kennedy; Kirsten Malpas; Leona Dann; Carl Shuker; Colleen Dunne; Philip Wood; Jay Magaziner; David Marsh; Irewin Tabu; Cyrus Cooper; Philippe Halbout; Muhammad Kassim Javaid; Kristina Åkesson; Anastasia Soulié Mlotek; Eric Brûlé-Champagne; Roger Harris Journal: Arch Osteoporos Date: 2022-08-02 Impact factor: 2.879